ANNOUNCEMENT {#s1}
============

Hand, foot, and mouth disease (HFMD) is a common infectious disease that mostly affects children less than 5 years of age; it is caused mainly by *Enterovirus* species A ([@B1]). Enterovirus A71 and coxsackievirus A16 (CVA16) are the two historically well-known serotypes. CVA6, another serotype of *Enterovirus* species A, family *Picornaviridae*, which has been involved in sporadic cases or outbreaks documented worldwide since 2008 ([@B2][@B3][@B9]), has been one of the major etiological agents associated with HFMD outbreaks in mainland China in recent years ([@B10]). Although CVA6 infection generally results in mild and self-limited disease, rarely it can cause severe disease such as aseptic meningitis, encephalitis, and even death ([@B11]); therefore, it is very important to understand the molecular characteristics of CVA6.

CVA6 is a nonenveloped positive single-stranded RNA virus with a genome length of about 7.4 kb. The genome is composed of a 5′ untranslated region (UTR), the structural protein P1 region, the functional protein P2 and P3 regions, and a 3′ UTR ([@B12]). To date, all CVA6 strains can be classified into four genotypes (A, B, C, or D) based on complete VP1 gene phylogenetic analyses ([@B10]). In Qingdao, China, in 2017, a throat swab sample from a 5-year-old girl suspected to have severe HFMD was sent to the Qingdao Municipal Center for Disease Control and Prevention and was identified as CVA6 positive by a commercial real-time reverse transcription-PCR (RT-PCR) test (Liferiver Bio-Tech, Shanghai, China); the throat swab sample from this girl was then transfected into a rhabdomyosarcoma cell line (RD cells) according to standard protocols ([@B13]). The infected cells were cultured for 2 passages until cytopathic effect occurred. The supernatant was harvested and stored at −80°C. Viral RNA was extracted with the MagNA Pure LC total nucleic acid isolation kit (product no. REF03038505001; Roche) according to the manufacturer's recommended protocol. RT-PCR was conducted to amplify the complete genome by using the PrimeScript One Step RT-PCR kit v.2 (product no. RR055A; TaKaRa) ([@B14]). The amplified cDNA product was sequenced by BGI (Beijing, China). Primers for PCR amplification and sequencing were designed according to the existing reference sequences ([Table 1](#tab1){ref-type="table"}). Sequences were assembled according to the sequence chromatograms. For the regions not measured, primers for sequencing were designed according to the existing sequences. Finally, the sequences could be spliced into a complete sequence and compared with the reference sequence. Sequencing was performed by Sanger dideoxy sequencing. Sequencing results were assembled with DNASTAR v.6.0 software, and Mega v.7.0 software was utilized to perform sequence alignment and phylogenetic analysis. The phylogenetic tree was constructed with the neighbor-joining method and a Kimura two-parameter model, with 1,000 bootstrap replicates.

###### 

Primers used in this study

  Oligonucleotide   Sequence (5′ to 3′)         Position (nucleotide range)   Purpose(s)
  ----------------- --------------------------- ----------------------------- ---------------------------------------------
  1CA6F             CGGTTAAAACAGCCTGTGGG        1--17                         CVA6 genome sequencing
  1268CA6R          CCCGAGCGGTACAAGTAGTG        1249--1268                    CVA6 genome sequencing
  1113CA6F          TACTCGCCCTGACGTGTC          1113--1130                    CVA6 genome sequencing
  2059CA6R          GGGAACCAGACCATTGAGTGT       2039--2059                    CVA6 genome sequencing
  1762CA6F          CTTACAACTGATGACGGGAC        1762--1781                    CVA6 genome sequencing
  2717CA6R          TTCACCTCCACAACYCCTACYAGC    2694--2717                    CVA6 genome sequencing
  2333CA6F          TAGACACCCCCACTGAGGCT        2333--2352                    CVA6 genome sequencing, CVA6 VP1 sequencing
  3530CA6R          GGCAGTAATACACTCCTGTTTGAC    3530--3553                    CVA6 genome sequencing, CVA6 VP1 sequencing
  3265CA6F          CGCCAAACAATAACTAACACTGC     3265--3287                    CVA6 genome sequencing
  3714CA6F          GTGATTGGTATCGTGTCCACTG      3714--3735                    CVA6 2C sequencing
  4579CA6R          GCGGAAGTGAGTACACACTAGAGTG   4555--4579                    CVA6 genome sequencing, CVA6 2C sequencing
  4441CA6F          CAGTTCAAGAGCAAACACCGTAT     4441--4463                    CVA6 genome sequencing
  5760CA6R          AGGTACAAACATTGAGGGCATG      5739--5760                    CVA6 genome sequencing
  5642CA6F          CCCTTGACACTAATGAGAAATTCAG   5642--5666                    CVA6 genome sequencing
  6921CA6R          AGCAACCATGTTGAGTTCATCC      6921--6942                    CVA6 genome sequencing, CVA6 3D sequencing
  6493CA6F          GAAGCCAGCAGTTTGAATGACTC     6493--6515                    CVA6 genome sequencing
  7400CA6R          GTATAACAAATTTACCCCCACCAGT   7400--7424                    CVA6 genome sequencing
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The full-length genome of the CVA6 strain 17ES4/QD/CHN/2017 was found to contain 7,435 nucleotides (nt), excluding the poly(A) tail. The 5′ UTR was found to contain 745 nt, followed by a single open reading frame encoding the structural protein P1 (2,610 nt), the nonstructural proteins P2 (1,734 nt) and P3 (2,259 nt), and the 3′ UTR. The isolated CVA6 strain genome has a G+C content of 47.4%. Phylogenetic analyses estimated the viral gene relationships with selected CVA6 strains from GenBank. The results of the phylogenetic analyses show that 17ES4/QD/CHN/2017 belongs to subgenotype D3a, based on phylogenetic analysis of the VP1 gene. Moreover, strain 17ES4/QD/CHN/2017 is closely related to strain XS-45 (GenBank accession no. [MH536772.2](https://www.ncbi.nlm.nih.gov/nuccore/MH536772.2)), with 98% nucleotide identity, based on the results of a complete-genome BLAST search ([Fig. 1](#fig1){ref-type="fig"}).
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The full-length sequence of 17ES4/QD/CHN/2017, isolated in Qingdao in 2017, was deposited in GenBank under accession no. [MN689954](https://www.ncbi.nlm.nih.gov/nuccore/MN689954).
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